Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04227327
Title Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Milano Bicocca

Her2-receptor negative breast cancer


Abemaciclib + Letrozole

Abemaciclib + Anastrozole

Age Groups: adult | senior
Covered Countries ITA

No variant requirements are available.